{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260527462059/en/Travere-Therapeutics-Receives-Notice-of-Allowance-from-the-U.S.-Patent-and-Trademark-Office-for-U.S.-Patent-Application-Directed-to-Certain-Methods-of-Using-FILSPARI%C2%AE-sparsentan-in-IgA-Nephropathy", "message": "News view counter 760907 successfully enlarged"}